Palantir Alex Karp Says There Was No Domestic Surveillance
Palantir CEO Alex Karp asserts there was never a domestic surveillance plan in the Anthropic-DoD dispute, detailing t...
When To Revisit Your Budget Plan
Timely reviews keep plans relevant. This intro covers triggers and a simple process to revisit and revise your budget plan.
20,766 articles
Iran Knocks Trump Back: Markets React as Oil Surges
Stocks and oil prices moved suddenly as the latest strikes sharpen U.S.-Iran tensions. Trump faces new political head...
There BDCs Paying Yields: Can They Sustain the High Payouts
Three BDCs flash double-digit yields, but sustainability varies. FSK and SCM face earnings pressure and dividend cuts...
Tiny ETF Surges 289% as Oil Hovers Near $80 Barrels
A little-known ETF with amplified crude exposure has jumped 289% year-to-date as oil holds near $80, highlighting the...
Crypto Tried Visa Mastercard: Banks Bet on Blockchain Buyouts
Mastercard unveiled an up to $1.8 billion deal to buy BVNK, a blockchain payments infrastructure company, in a move t...
Federal Reserve Holds Interest Rates Steady in March
The Federal Reserve holds interest rates steady at the 5.25%-5.50% range as inflation runs near target and the labor ...
Rocket Lab Volatility Sparks New Weekly Income ETF Strategy
A new ETF aims to monetize the price swings of Rocket Lab and other space names by selling weekly put spreads to fund...
Investors Bracing Wild Trading as Triple Witching Strikes
Friday marks the first triple witching of 2026 as Iran tensions flare, prompting investors to brace for volatile move...
Mortgage Rates Breaking Higher Amid Iran Tensions, Oil Swings
Iran tensions and hawkish policy signals are lifting yields, putting mortgage rates breaking higher and spring housin...
The 2026 COLA Three Months in: Is It Keeping Up with Inflation So Far?
Three months into 2026, the 2.8% COLA boosted average benefits to $2,071, but a surge in energy prices and Medicare w...
TJX Hits $60B Revenue, Missed Memo Just Billion Moment
TJX shattered a retail milestone by exceeding $60 billion in annual revenue for the first time, signaling enduring st...
Pfizer Could Year-End Target Hit on 2-to-1 Trial Payoff
Pfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status